Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.
about
A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, IndiaThe case for reactive mass oral cholera vaccinationsCritical analysis of compositions and protective efficacies of oral killed cholera vaccinesVaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio choleraePrinciples of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsMucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motilityVibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, IndiaMaximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with choleraA large study on immunological response to a whole-cell killed oral cholera vaccine reveals that there are significant geographical differences in response and that O blood group individuals do not elicit a higher responseCholera in India: an analysis of reports, 1997-2006Killed oral cholera vaccines: history, development and implementation challengesVibrio cholerae: lessons for mucosal vaccine design.Oral vaccination: where we are?Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.Vibrio cholerae ghosts (VCG) exert immunomodulatory effect on dendritic cells for enhanced antigen presentation and induction of protective immunity.Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.Preparation and immunogenicity of conjugate based on hydrazine-treated lipopolysaccharide antigen of Vibrio cholerae O139.A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in EthiopiaAntibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian AdultsConstruction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunitNeedle-free vaccine delivery.Genomic correlates of variability in immune response to an oral cholera vaccine.Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio choleraeSafety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea.New-generation vaccines against cholera.Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era.Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings.Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model.Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis.Causes of impaired oral vaccine efficacy in developing countries.Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.CholeraThe Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnershipsBivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial
P2860
Q21144301-CA85892A-5A84-4AE5-A55F-905BA9EC46A4Q21144515-5F595296-0B42-4420-8ECE-D4ABB3AA5EB5Q26823170-654A6C00-BEA9-4072-AC38-141A34543E00Q27004488-2FE735DD-8FD3-48DF-ADE0-5D83F24ADA16Q28384852-00153C1A-5503-4710-B1E8-D9CE1D270CB3Q30496874-0F429291-22A6-423A-8C1A-B1DDBFFA316FQ33572955-DBD80391-FD88-44E8-AA00-74FFA96CDB83Q33578033-95FD3957-761A-481A-9C61-B45F0568DC2BQ33588522-4A9BFB55-BD8E-4055-8F7C-6382F69606E0Q33606727-170023A2-9E03-410B-82E1-B81EA07593E4Q33689166-48E6AC8F-5792-43B7-A65F-6179408F8053Q34087755-5CA825B3-F4C9-4618-A2B9-A207C8AD5D01Q34562952-E2EDE15A-1875-4706-A889-AB627F79CEC5Q34660422-AB9FC4F7-C050-4C84-A596-30F296692A1DQ34883543-5B548C61-9D5A-4A1B-8FD2-BF01825CFAF8Q35033443-485672BF-7315-43F2-ACDD-09BCC2792B88Q35170821-3DC0A5E1-1914-4BCD-8049-263652AC3E42Q35214487-AB34DB37-B997-43DF-AD13-4A3CDD2B74F5Q36026263-5F032639-57B2-4DA2-A98B-47BD7D897BDFQ36053849-4C0AB991-1E73-453C-8CE1-4E80E026606FQ36480147-E661B895-7626-490E-9DA3-F36E0BC2F36FQ36945838-D5EEEE71-E0C9-4C79-B0E5-87292D9E6680Q37102102-6F594347-E1DF-4328-919B-17B5AC433BC9Q37274863-1A4EF17E-6293-4E19-AA44-65374576AF18Q37710341-43E12430-A88B-4703-9BE6-A0040517E439Q37953796-8A590786-0978-400D-B5A6-282F332870C7Q38376033-53C42812-9B58-465C-84A4-11361D3AAE59Q41039072-95D06D06-FAA8-4548-B17A-F290878591E3Q46125947-E4B3A342-D0E8-4D5E-B343-87636BE4FA45Q46246286-016C318F-2334-4B41-85A7-B31D0A3723B1Q47410855-BF2ADE4F-71D6-45DF-A723-64F9B390D029Q47794110-CD6B26FE-B4FC-4BB1-A751-B2D0FDFC16F7Q48344793-89101C23-F745-4720-B887-F5905507719DQ55890255-FCD3ADAE-333D-4D8C-BE84-ABD38D6944A8Q57481187-14C4F319-58A6-4BDF-8AE9-75DFAF713E31Q57940864-38A231A0-86D4-4C42-9022-7FA503E89B85
P2860
Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Safety and immunogenicity of a ...... ral cholera vaccine in adults.
@en
Safety and immunogenicity of a ...... ral cholera vaccine in adults.
@nl
type
label
Safety and immunogenicity of a ...... ral cholera vaccine in adults.
@en
Safety and immunogenicity of a ...... ral cholera vaccine in adults.
@nl
prefLabel
Safety and immunogenicity of a ...... ral cholera vaccine in adults.
@en
Safety and immunogenicity of a ...... ral cholera vaccine in adults.
@nl
P2093
P1433
P1476
Safety and immunogenicity of a ...... ral cholera vaccine in adults.
@en
P2093
Anna Lena Lopez
Dang Duc Anh
Do Gia Canh
Jacqueline Deen
John Clemens
Nguyen Hong Son
Phan Thi Long
Rodney Carbis
Seong Hye Shin
Seung Hyun Han
P304
P356
10.1016/J.VACCINE.2006.09.049
P407
P577
2006-09-29T00:00:00Z